Holmdel Pharmaceuticals - InnoPran XL - Ownership and Business Overview

Life ScienceCompany

Holmdel Pharmaceuticals - InnoPran XL Ownership

Who owns Holmdel Pharmaceuticals - InnoPran XL?

Holmdel Pharmaceuticals - InnoPran XL is owned by ANI Pharmaceuticals. It was acquired on February 24, 2017.

Holmdel Pharmaceuticals - InnoPran XL Business Overview

Where is Holmdel Pharmaceuticals - InnoPran XL headquartered?

Holmdel Pharmaceuticals - InnoPran XL is headquartered in Cranford, New Jersey.

What sector is Holmdel Pharmaceuticals - InnoPran XL in?

Holmdel Pharmaceuticals - InnoPran XL is a life science company.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 248 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 225 by strategics.

Holmdel Pharmaceuticals LP - InnoPran XL

Cranford, New Jersey
United States,

Holmdel Pharmaceuticals LP - InnoPran XL is a beta adrenergic blocker indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions.


 Subscribe to unlock this and 201,649
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.